ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,354.65
1.09%
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs Yen
161.024
0.07%
Brent Oil
85.375
0.31%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKTG:9RSSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKEU:SWPSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneEU:SWPSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneLSE:0MN5Sword Group Se
2024/07/0114 : 45GlobeNewswire Inc.Sword Group : Acquisitions en Grande-BretagneTG:9RSSword Group
2024/07/0114 : 45GlobeNewswire Inc.Sword Group: Acquisitions in the UKLSE:0MN5Sword Group Se
2024/07/0114 : 38Alliance NewsAlliance NewsIrish slowdown in manufacturing accelerates in June; outlook positive
2024/07/0114 : 33PR Newswire (US)Global Times: CPC members reach 99.185 million
2024/07/0114 : 31GlobeNewswire Inc.Kalmar’s financial information in 2024
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:INHCInduction Healthcare Group Plc
2024/07/0114 : 30Alliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:PRVPorvair Plc
2024/07/0114 : 30Alliance NewsAlliance NewsAlliance News UK - start of day
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ LSE:0RADOse Immunotherapeutics Sa
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’LSE:0RADOse Immunotherapeutics Sa
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’TG:6OPOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ EU:OSEOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ TG:6OPOSE Immunotherapeutics
2024/07/0114 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024TG:FRUMultitude SE
2024/07/0114 : 30GlobeNewswire Inc.Kalmar specifies its outlook for 2024
2024/07/0114 : 30GlobeNewswire Inc.Sampo plc’s share buybacks 28 June 2024
2024/07/0114 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
2024/07/0114 : 30GlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024XE:FRUMultitude SE
2024/07/0114 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
2024/07/0114 : 30GlobeNewswire Inc.Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24.00 in cash per Common Share and per SDR
2024/07/0114 : 30PR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions
2024/07/0114 : 30PR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions

最近閲覧した銘柄

NYSE
NKE
Nike
CCOM
US500
US 500
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
NYSE
JPM
JP Morgan Chase
NYSE
MCD
McDonalds
CCOM
US100
US Tech 100
COIN
SOLUSD
Solana
CCOM
US30
US 30
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有